4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions

Not Applicable

Completed

• Conditions: Pain

• Registration Number: NCT00121329
• Lead Sponsor: Oregon Health and Science University

Brief Summary

Recent studies have investigated the use of local anesthetics (i.e. lidocaine, mepivacaine) to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy and office hysteroscopy. Local anesthetic injected into the uterine cavity has been demonstrated effective in some studies at decreasing patient pain associated with these intrauterine procedures at an anesthetic concentration of at least 2%. Based on this evidence, we hypothesized that an intrauterine lidocaine infusion may reduce patient pain during first trimester abortions.

Detailed Description

Not available

Study Timeline

• Study Completion: 2004-12
• Status Verified: 2005-07
• Study First Submitted: 2005-07-13
• Study First Submitted QC: 2005-07-19
• Last Update Submitted: 2005-07-19
• Study First Posted: 2005-07-21
• Last Update Posted: 2005-07-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• Age > 18 years old
• Good general health
• English speaking
• Confirmation of gestational age by ultrasound
• Body weight > 100 lbs.
• Pregnancy < 11 weeks

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
VAS scores during cervical dilation and uterine aspiration

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction, symptoms, lidocaine levels

Trial Locations

Locations (1)

Planned Parenthood of the Columbia Willamette; 🇺🇸 Portland, Oregon, United States